Loading chat...
RI H7075
Bill
Status
1/14/2026
Primary Sponsor
Michelle McGaw
Click for details
AI Summary
-
Requires all individual and group health insurance plans with prescription coverage to cover at least one type of glucagon auto-injector, nasal spray, or formulation not requiring reconstitution, effective January 1, 2027
-
Eliminates copayments and deductibles for up to two glucagon devices per 12-month plan year
-
Applies to accident and sickness insurers, nonprofit hospital service corporations, nonprofit medical service corporations, and health maintenance organizations
-
Allows deductibles to apply for health plans paired with federally qualified health savings accounts under 26 U.S.C. § 223
-
Permits health plans to implement coverage prior to the January 1, 2027 effective date
Legislative Description
Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.
Insurance
Last Action
Committee recommended measure be held for further study
1/29/2026